Article Details

Drug Pricing Policy in the Inflation Reduction Act a Moderate But Manageable Negative to Biopharma

Retrieved on: 2022-08-02 15:49:06

Tags for this article:

Click the tags to see associated articles and topics

Drug Pricing Policy in the Inflation Reduction Act a Moderate But Manageable Negative to Biopharma. View article details on HISWAI: https://www.morningstar.com/articles/1106465/drug-pricing-policy-in-the-inflation-reduction-act-a-moderate-but-manageable-negative-to-biopharma

Excerpt

... Inflation Reduction Act of 2022 in our Big Biopharma valuation models. ... Part D cost-sharing to biopharma firms with more expensive drugs; ...

Article found on: www.morningstar.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up